1. Home
  2. HTH vs ANIP Comparison

HTH vs ANIP Comparison

Compare HTH & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTH
  • ANIP
  • Stock Information
  • Founded
  • HTH 1998
  • ANIP 2001
  • Country
  • HTH United States
  • ANIP United States
  • Employees
  • HTH N/A
  • ANIP N/A
  • Industry
  • HTH Major Banks
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTH Finance
  • ANIP Health Care
  • Exchange
  • HTH Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • HTH 2.1B
  • ANIP 2.0B
  • IPO Year
  • HTH 2004
  • ANIP N/A
  • Fundamental
  • Price
  • HTH $34.02
  • ANIP $95.36
  • Analyst Decision
  • HTH Hold
  • ANIP Strong Buy
  • Analyst Count
  • HTH 1
  • ANIP 9
  • Target Price
  • HTH $32.00
  • ANIP $89.11
  • AVG Volume (30 Days)
  • HTH 422.1K
  • ANIP 394.4K
  • Earning Date
  • HTH 10-23-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • HTH 2.11%
  • ANIP N/A
  • EPS Growth
  • HTH 27.10
  • ANIP N/A
  • EPS
  • HTH 2.22
  • ANIP N/A
  • Revenue
  • HTH $1,233,449,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • HTH N/A
  • ANIP $39.36
  • Revenue Next Year
  • HTH $1.15
  • ANIP $9.45
  • P/E Ratio
  • HTH $15.39
  • ANIP N/A
  • Revenue Growth
  • HTH 4.92
  • ANIP 38.68
  • 52 Week Low
  • HTH $26.67
  • ANIP $52.50
  • 52 Week High
  • HTH $36.14
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • HTH 52.12
  • ANIP 62.70
  • Support Level
  • HTH $33.40
  • ANIP $96.08
  • Resistance Level
  • HTH $35.21
  • ANIP $99.39
  • Average True Range (ATR)
  • HTH 0.62
  • ANIP 2.35
  • MACD
  • HTH -0.28
  • ANIP -0.75
  • Stochastic Oscillator
  • HTH 22.63
  • ANIP 54.75

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: